Sign Out
Human prothrombin complex products neutralize the effect of vitamin K antagonist treatment. No interaction studies have been performed.
Interference with biological testing: When performing clotting tests, which are sensitive to heparin in patients receiving high doses of human prothrombin complex, the heparin as a constituent of the administered product must be taken into account.
Continue with Google